APEIRON Biologics AG Revenue and Competitors
Estimated Revenue & Valuation
- APEIRON Biologics AG's estimated annual revenue is currently $930k per year.
- APEIRON Biologics AG's estimated revenue per employee is $155,000
Employee Data
- APEIRON Biologics AG has 6 Employees.
- APEIRON Biologics AG grew their employee count by -45% last year.
APEIRON Biologics AG's People
| Name | Title | Email/Phone |
|---|
APEIRON Biologics AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $10.5M | 68 | 26% | N/A | N/A |
#2 | $2.3M | 15 | 36% | N/A | N/A |
#3 | $0.9M | 6 | -45% | N/A | N/A |
What Is APEIRON Biologics AG?
APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. \n\nOur company has a well balanced portfolio with one product on the market and several promising products from clinical to pre-clinical stages. As for the product on the market, APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients. We out-licensed Qarziba® globally to EUSA Pharma Ltd, for which it holds exclusive rights to this product.\n\nAPEIRON’s key projects and technologies are bolstered by a strong patent portfolio with broad territorial coverage. Our development expertise is validated through partnerships with leading global pharmaceutical companies and academic institutions.
keywords:N/A
N/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
-45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Wien
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 6 | -50% | N/A |
#2 | $0.8M | 6 | 50% | N/A |
#3 | $0.8M | 6 | -14% | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.6M | 7 | -12% | N/A |